Form4insider filings, from the source

SEC Form 4 · accession 0001012975-15-000707

CytomX Therapeutics, Inc. · CTMX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Mark J Levin
10% Owner
Kevin P Starr
10% Owner
TRV GP, LLC
10% Owner
Period of report
Oct 14, 2015
Accepted (ET)
Oct 23, 2015 · 7:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001501989

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Oct 14, 2015C8,670,351—A8,670,351D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series B-1 Preferred StockF3,F1,F2—Oct 14, 2015C8,105,314D——Common Stock8,105,3140D
Series C Preferred StockF3,F1,F2—Oct 14, 2015C565,037D——Common Stock565,0370D

Explanation of responses